These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15940664)

  • 21. Biodegradable thermoresponsive hydrogels for aqueous encapsulation and controlled release of hydrophilic model drugs.
    Huang X; Lowe TL
    Biomacromolecules; 2005; 6(4):2131-9. PubMed ID: 16004455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poly(ethylene glycol) hydrogels formed by conjugate addition with controllable swelling, degradation, and release of pharmaceutically active proteins.
    van de Wetering P; Metters AT; Schoenmakers RG; Hubbell JA
    J Control Release; 2005 Feb; 102(3):619-27. PubMed ID: 15681084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA delivery from photocrosslinked PEG hydrogels: encapsulation efficiency, release profiles, and DNA quality.
    Quick DJ; Anseth KS
    J Control Release; 2004 Apr; 96(2):341-51. PubMed ID: 15081223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor.
    Cai S; Liu Y; Zheng Shu X; Prestwich GD
    Biomaterials; 2005 Oct; 26(30):6054-67. PubMed ID: 15958243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel degradable poly(ethylene glycol) hydrogels for controlled release of protein.
    Zhao X; Harris JM
    J Pharm Sci; 1998 Nov; 87(11):1450-8. PubMed ID: 9811505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of crosslinking density on swelling and mechanical properties of PEGDA400/PCLTMA900 hydrogels.
    Metz J; Gonnerman K; Chu A; Chu TM
    Biomed Sci Instrum; 2006; 42():389-94. PubMed ID: 16817639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tailoring the network properties of Ca2+ crosslinked Aloe vera polysaccharide hydrogels for in situ release of therapeutic agents.
    McConaughy SD; Kirkland SE; Treat NJ; Stroud PA; McCormick CL
    Biomacromolecules; 2008 Nov; 9(11):3277-87. PubMed ID: 18937400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sustained release of bee venom peptide from biodegradable thermosensitive PLGA-PEG-PLGA triblock copolymer-based hydrogels in vitro.
    Qiao M; Chen D; Ma X; Hu H
    Pharmazie; 2006 Mar; 61(3):199-202. PubMed ID: 16599259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An approach to modulate degradation and mesenchymal stem cell behavior in poly(ethylene glycol) networks.
    Hudalla GA; Eng TS; Murphy WL
    Biomacromolecules; 2008 Mar; 9(3):842-9. PubMed ID: 18288800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular responses to degradable cyclic acetal modified PEG hydrogels.
    Kaihara S; Matsumura S; Fisher JP
    J Biomed Mater Res A; 2009 Sep; 90(3):863-73. PubMed ID: 18615467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel enzymatic technique for limiting drug mobility in a hydrogel matrix.
    Burke MD; Park JO; Srinivasarao M; Khan SA
    J Control Release; 2005 May; 104(1):141-53. PubMed ID: 15866341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant protein-co-PEG networks as cell-adhesive and proteolytically degradable hydrogel matrixes. Part II: biofunctional characteristics.
    Rizzi SC; Ehrbar M; Halstenberg S; Raeber GP; Schmoekel HG; Hagenmüller H; Müller R; Weber FE; Hubbell JA
    Biomacromolecules; 2006 Nov; 7(11):3019-29. PubMed ID: 17096527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poly(ethylene glycol) methacrylate/dimethacrylate hydrogels for controlled release of hydrophobic drugs.
    Diramio JA; Kisaalita WS; Majetich GF; Shimkus JM
    Biotechnol Prog; 2005; 21(4):1281-8. PubMed ID: 16080712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plum-pudding gels as a platform for drug delivery: understanding the effects of the different components on the diffusion behavior of solutes.
    Salvati A; Söderman O; Lynch I
    J Phys Chem B; 2007 Jun; 111(25):7367-76. PubMed ID: 17547442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controlling rigidity and degradation of alginate hydrogels via molecular weight distribution.
    Kong HJ; Kaigler D; Kim K; Mooney DJ
    Biomacromolecules; 2004; 5(5):1720-7. PubMed ID: 15360280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Degradable dextran hydrogels: controlled release of a model protein from cylinders and microspheres.
    Franssen O; Vandervennet L; Roders P; Hennink WE
    J Control Release; 1999 Aug; 60(2-3):211-21. PubMed ID: 10425327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel biodegradable hydrogels based on pachyman and its derivatives for drug delivery.
    Hu Y; Zhou X; Lu Y; Hu C; Hu X
    Int J Pharm; 2009 Apr; 371(1-2):89-98. PubMed ID: 19215726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlled release of an anthrax toxin-neutralizing antibody from hydrolytically degradable polyethylene glycol hydrogels.
    Liang Y; Coffin MV; Manceva SD; Chichester JA; Jones RM; Kiick KL
    J Biomed Mater Res A; 2016 Jan; 104(1):113-23. PubMed ID: 26223817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant gelatin hydrogels for the sustained release of proteins.
    Sutter M; Siepmann J; Hennink WE; Jiskoot W
    J Control Release; 2007 Jun; 119(3):301-12. PubMed ID: 17467099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of chondroitin sulfate and its interpenetrating polymer network hydrogels for sustained-drug release.
    Wang SC; Chen BH; Wang LF; Chen JS
    Int J Pharm; 2007 Feb; 329(1-2):103-9. PubMed ID: 16996709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.